GSK · company speakers →
unveiled insights into GSK4418959 (IDE275), a Werner (WRN) helicase inhibitor that binds WRN reversibly and demonstrated the ability to induce DNA damage in solid tumors with high microsatellite instability, while sparing microsatellite stable cells.
Is this you? Claim this profile →
No public contact links on file.
Sourcing speakers for your event?
Browse the speaker directory →